Back Login to subscribe 🔔 Set Alert

LNAI Lunai Bioworks Inc. Common Stock

15 min delay

Loading...

Loading...

Loading...

Loading options…

CALLS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

PUTS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

Loading insider data…

Date	Headline	Sentiment
	Lunai Bioworks' BioSymetrics And BrainStorm Therapeutics Announce Strategic Collaboration And LOI Integrating AI Discovery, Human Brain Organoid Modeling, And In Vivo Validation To Generate Differentiated Neurology Assets For Pharmaceutical Partnering And Development	70.29%
	Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times	92.56%
	Federal Judge Granted Lunai Bioworks Permission On May 20 To Conduct Expedited Third-Party Discovery To Identify Naked Short Sellers Of Lunai Common Stock Through 2025-2026	51.93%
	Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending	64.4%
	Lunai Bioworks Announces 1-For-8 Reverse Stock Split Effective May 22	82.51%
	Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K	97.19%
	Lunai Bioworks Approves Reverse Stock Split At Ratio Of 1-For-3 To 1-For-30	95.13%
	Lunai Bioworks Files Delaware Federal Lawsuit Against Naked Short-Sellers Who Traded ~554M Shares On March 17, 2026, Representing 15.3 Times Company's Total Outstanding Shares	63.18%
	12 Health Care Stocks Moving In Tuesday's Pre-Market Session	93.45%
	12 Health Care Stocks Moving In Monday's After-Market Session	96.74%

1
2
›